Financials
- Market Capitalization 1.05 B
- Employee 1 002
- Founded 2007
- CEO N/A
- Website www.castlebiosciences.com
- Headquarter Delaware, United States
- FIGI BBG006YWVSR3
- Industry Diagnostics & Research
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2085 | PSNL Personalis, Inc. - Common Stock | 16.80 USD | -1.64% | +0.84% | +41.65% | +251.46% | 1.79 B USD | ||
| 2395 | OPK Opko Health, Inc. - Common Stock | 1.50 USD | -0.66% | +0.67% | -9.09% | +6.38% | 1.12 B USD | ||
| 2515 | ACRS Aclaris Therapeutics, Inc. - Common Stock | 6.16 USD | -0.48% | -3.14% | +15.36% | +232.97% | 906.75 M USD | ||
| 2874 | FLGT Fulgent Genetics, Inc. - Common Stock | 19.95 USD | +0.71% | -0.30% | +2.36% | -15.57% | 548.93 M USD |
Frequently asked questions about Castle Biosciences, Inc. Common Stock
What is the Castle Biosciences, Inc. Common Stock stock price today?
The current price of Castle Biosciences, Inc. Common Stock (CSTL) is 34.26. Over the past 24 hours, the stock has changed by +0.53%. Follow the CSTL chart for real-time price dynamics.
What is the stock ticker of Castle Biosciences, Inc. Common Stock?
Castle Biosciences, Inc. Common Stock trades under the ticker CSTL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Castle Biosciences, Inc. Common Stock stock going up?
CSTL has changed by +6.60% over the last week, +43.17% over the last month, and +39.18% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Castle Biosciences, Inc. Common Stock?
Castle Biosciences, Inc. Common Stock currently has a market capitalization of 1.05 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Castle Biosciences, Inc. Common Stock earnings last quarter?
Last quarter, Castle Biosciences, Inc. Common Stock reported earnings of -0.07 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Castle Biosciences, Inc. Common Stock revenue for the last quarter?
Castle Biosciences, Inc. Common Stock reported quarterly revenue of 103.36 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Castle Biosciences, Inc. Common Stock net income for the last quarter?
Castle Biosciences, Inc. Common Stock reported net income of -2.06 M for the last quarter. The previous quarter showed -14.52 M, which means net income changed by +85.81%.
How many employees does Castle Biosciences, Inc. Common Stock have?
As of the latest available data, Castle Biosciences, Inc. Common Stock has 1 002 employees. Workforce size can provide additional context about the company's scale and operations.
What is Castle Biosciences, Inc. Common Stock EBITDA?
Castle Biosciences, Inc. Common Stock EBITDA is 815 K, and its EBITDA margin is 0.79%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Castle Biosciences, Inc. Common Stock stock?
You can buy Castle Biosciences, Inc. Common Stock (CSTL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Castle Biosciences, Inc. Common Stock stock?
Investing in Castle Biosciences, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CSTL chart and related analysis on metatrader.com as part of your research.